Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q3 2022 · 10-Q
Revenue$67.73M$67.73M+44.9% vs Q3 2021 Net Income-$131.15M-$131.15MN/M vs Q3 2021 EPS Diluted-$1.09-$1.09N/M vs Q3 2021 Operating Income-$127,697,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$90,410,000N/M Margins · derivedOperating margin-188.5%+33.1 pt vs Q3 2021
Net margin-193.6%+47.4 pt vs Q3 2021
ended Sep 30, 2022 · filed Oct 27, 2022 · 27 d after period end